Dr. SHENG Jin graduated from Sun Yat-sen University in 2016 with an M.D. in oncology and an M.D. in clinical medicine. In 2019, Dr. Sheng completed her postdoctoral training in clinical medicine at Zhejiang University School of Medicine. She has been involved in molecular gene analysis and precision treatment of lung cancer and digestive tract tumors. She is committed to clinical practice, scientific research and clinical teaching of lung cancer and digestive tract tumors. She has published more than 20 clinical and translational research papers in NPJ Precision Oncology, The Oncologist, Lung Cancer and other international oncology journals, chaired and participated in a number of national and provincial medical research projects, and participated in more than 50 international and domestic multi-center clinical studies on anti-tumor drugs. She has participated in the preparation of the 2023 Chinese guidelines for the prevention and treatment of nausea and vomiting related to anti-tumor therapy.

Member and Secretary of the CSCO Expert Committee on Tumor Support and Rehabilitation Therapy, Chinese Society of Clinical Oncology

Member of the Abdominal Tumor Medical Comprehensive Rehabilitation Branch, Chinese Medical Education Association

Member of the Youth Committee of Medical Oncology, Zhejiang Anti-Cancer Association

Member of the Special Committee for Clinical Research of Anti-Tumor Drugs, Zhejiang Mathematical Medicine Society